tiprankstipranks
Advertisement
Advertisement

ACET Stock Latest News

Adicet Bio completes prula-cel Phase 1 SLE analysis
Company AnnouncementsAdicet Bio completes prula-cel Phase 1 SLE analysis
3d ago
8K
ACET
Adicet Bio completes last patient visit for analysis of prula-cel in lupus
PremiumThe Fly
Adicet Bio completes last patient visit for analysis of prula-cel in lupus
3d ago
ACET
Adicet Bio announces FDA clearance of IND application for ADI-212
PremiumThe Fly
Adicet Bio announces FDA clearance of IND application for ADI-212
8d ago
ACET
Adicet Bio: Buy Rating Reiterated on Strong 2Q26 Results, Extended Cash Runway, and Multiple Upcoming Clinical Catalysts Supporting $27 DCF-Based Price Target
PremiumRatings
Adicet Bio: Buy Rating Reiterated on Strong 2Q26 Results, Extended Cash Runway, and Multiple Upcoming Clinical Catalysts Supporting $27 DCF-Based Price Target
25d ago
ACET
Adicet Bio price target lowered to $90 from $100 at Guggenheim
PremiumThe Fly
Adicet Bio price target lowered to $90 from $100 at Guggenheim
29d ago
ACET
Adicet Bio reports Q2 EPS ($1.99), consensus ($1.64)
PremiumThe FlyAdicet Bio reports Q2 EPS ($1.99), consensus ($1.64)
30d ago
ACET
Adicet Bio Stockholders Back Directors, Pay and Auditor
Premium
Company Announcements
Adicet Bio Stockholders Back Directors, Pay and Auditor
3M ago
8K
ACET
Adicet Bio reports Q1 EPS ($1.88), consensus ($3.08)
Premium
The Fly
Adicet Bio reports Q1 EPS ($1.88), consensus ($3.08)
4M ago
ACET
Adicet Bio assumed with a Buy at Jefferies
PremiumThe Fly
Adicet Bio assumed with a Buy at Jefferies
4M ago
ACET
Adicet Bio Issues Pre-Funded Warrant in Equity Exchange
PremiumCompany Announcements
Adicet Bio Issues Pre-Funded Warrant in Equity Exchange
4M ago
8K
ACET
Range, Adicet, Nova, PBF, Dorian: Insider Shake-Up
PremiumWeekend Updates
Range, Adicet, Nova, PBF, Dorian: Insider Shake-Up
5M ago
LPG
PBF
Adicet Bio: Cash Runway to 2027 and Differentiated Allogeneic Prula‑cel Pipeline Support Buy Rating and $27 Target
PremiumRatings
Adicet Bio: Cash Runway to 2027 and Differentiated Allogeneic Prula‑cel Pipeline Support Buy Rating and $27 Target
6M ago
ACET
Adicet Bio price target lowered to $27 from $50 at H.C. Wainwright
PremiumThe FlyAdicet Bio price target lowered to $27 from $50 at H.C. Wainwright
6M ago
ACET
Clinical Trial Uncertainty Puts Adicet Bio’s Prula-cel Program and Financial Outlook at Risk
Premium
Company Announcements
Clinical Trial Uncertainty Puts Adicet Bio’s Prula-cel Program and Financial Outlook at Risk
6M ago
ACET
Adicet Bio price target lowered to $100 from $128 at Guggenheim
Premium
The Fly
Adicet Bio price target lowered to $100 from $128 at Guggenheim
6M ago
ACET
Adicet Bio files $250M mixed securities shelf
PremiumThe Fly
Adicet Bio files $250M mixed securities shelf
6M ago
ACET
Adicet Bio reports Q4 EPS ($2.94), consensus ($2.99)
PremiumThe Fly
Adicet Bio reports Q4 EPS ($2.94), consensus ($2.99)
6M ago
ACET
ACET Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ACET Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
ACET
Adicet Bio price target adjusted to $50 from $9 at H.C. Wainwright
PremiumThe Fly
Adicet Bio price target adjusted to $50 from $9 at H.C. Wainwright
8M ago
ACET
Adicet Bio advances prula-cel autoimmune Phase 1 program
PremiumCompany AnnouncementsAdicet Bio advances prula-cel autoimmune Phase 1 program
8M ago
8K
ACET
Adicet Bio price target lowered to $18 from $128 at Canaccord
Premium
The Fly
Adicet Bio price target lowered to $18 from $128 at Canaccord
8M ago
ACET
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/31/25
Premium
Market News
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/31/25
8M ago
EB
VTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >